Not “Additive Free” or “Natural” – FDA Issues Warning Letters to Commercial Tobacco Manufacturers

Today, the FDA announced that it is issuing warning letters to three tobacco manufacturers for the use of “Additive-Free” and/or “Natural” claims on cigarette labeling.

Six years ago, Congress gave the FDA the responsibility to oversee the manufacture, marketing, distribution, and sale of tobacco products. A rigorous compliance and enforcement program helped FDA monitor regulated industry’s compliance with the laws designed to protect the public health generally and to reduce tobacco use by minors.

The FDA announced today that through ongoing surveillance efforts, they are issuing warning letters to three cigarette manufacturers, who describe their cigarettes on product labeling as “additive free” and/or “natural.” The warning letters are for violations of Section 911 of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FDA has determined that these products, described as “natural” and “additive-free” on their labeling, need a modified risk tobacco product (MRTP) order from the agency before they can be legally introduced as such into interstate commerce.

MRTPs can only be introduced into interstate commerce after scientific evidence to support them has been submitted to the FDA, and the FDA has issued an order permitting their marketing. To date, the FDA has not issued any orders that would permit label claims of reduced risk or harm to users and nonusers. These requirements were put in place so that American tobacco consumers are not misled about the harms of tobacco products.

Manufacturers must ensure their tobacco products and all related labeling and/or advertising comply with the FD&C Act and the FDA’s implementing regulations. Failure to obey federal tobacco laws may result in the FDA initiating action, including, but not limited to, civil money penalties, criminal prosecution, seizure, and/or injunction.

A manufacturer who seeks to claim that a product poses fewer risks than other tobacco products may submit a MRTP application to the FDA with scientific evidence to support that claim.

Read the full press release on this announcement here.

Anyone can report a potential tobacco-related violation of the FD&C Act by using the FDA’s Potential Tobacco Product Violation Reporting Form.

×

Upcoming Events

Attending any of these upcoming events? Have other events to share? Let us know! Email us at NNN@ITCMI.ORG to share your event information or to get on our list serve for event updates.

 

Native American Heritage Month | LEARN MORE

Smoking Cessation Leadership Center Webinar:  Cessation Under Siege | SCLC's next webinar, Building a system That Helped 300,000 People Quit Smoking will take place on December 2 from 2 - 3 pm ET.  Renee Fogelberg, MD, FACOG, Dipl. ABOM, NCMP, Clinical Lead Tobacco Cessation at Kaiser Permanente, Northern California will explain how to design and bild a new tobacco cessation workflow that integrates into electronic medical records and how to leverage strategic "teachable moments" where quit rates are statistically higher. | REGISTER

2025 Inter-Tribal Agriculture Council Annual Conference | Las Vegas, Nevada | LEARN MORE

56th Annual Michigan Indian Education Council Critical Issues Conference | LEARN MORE

Colorectal Cancer Awareness Month | LEARN MORE

National Network of Public Health Institutes Annual Conference | New Orleans, LA | LEARN MORE AND REGISTER

2026 National Council of Urban Indian Health Conference | Washington, D.C. | LEARN MORE AND REGISTER

Council of State and Territorial Epidemiologists Annual Conference | Boston, MA | LEARN MORE AND REGISTER